Trevena to Report Fourth Quarter and Full Year 2018 Results on March 13, 2019
March 04 2019 - 7:00AM
Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical
company focused on the development and commercialization of new and
innovative treatment options for patients in pain, today announced
that it will release its financial results for the fourth quarter
and full year ended December 31, 2018 before the market opens on
Wednesday, March 13, 2019.
The Company will host a conference call and webcast with the
investment community on Wednesday, March 13th at 8:00 a.m. Eastern
Time featuring remarks by Carrie Bourdow, President and CEO, Mark
Demitrack, SVP and Chief Medical Officer, and John Hamill, VP of
Finance.
What:
|
Trevena Fourth Quarter
and Full Year 2018 Results Conference Call |
Date: |
Wednesday, March 13,
2019 |
Time: |
8:00 a.m. ET |
Live
Call: |
Toll-Free: (855)
465-0180International: (484) 756-4313 |
Webcast:
|
investors.trevena.com |
Replay:
|
Toll-Free: (855)
859-2056 International: (404) 537-3406 Conference ID:
3496246(Available approximately one hour after the completion of
the live call until 11:59 p.m. ET on March 27, 2019) |
About TrevenaTrevena, Inc. is a
biopharmaceutical company focused on the development and
commercialization of new and innovative treatment options for
patients in pain. The Company has three novel and differentiated
investigational drug candidates, including IV oliceridine, for the
management of moderate to severe acute pain in hospitals, TRV250
for the treatment of acute migraine, and TRV734 for pain and/or
management of opioid dependence. In its preclinical programs,
Trevena is evaluating a set of novel S1P receptor modulators that
may offer a new, non-opioid approach to managing chronic pain.
For more information, please contact:
Investor Contact:Valter Pinto / Allison
SossKCSA Strategic CommunicationsPhone: 212-896-1254 /
212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief
Business OfficerTrevena, Inc.Phone: 610-354-8840
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Sep 2023 to Sep 2024